Reactions 1680, p239 - 2 Dec 2017 Neutropenia: case report A 54-year-old man developed neutropenia during treatment with fluorouracil [5-fluorouracil], folinic-acid [l-leucovorin], irinotecan and cetuximab. The man, who had a history of metastatic rectal cancer, started receiving chemotherapy with FOLFIRI-3 comprising of fluorouracil, folinic-acid and irinotecan along with cetuximab [routes and dosages not stated]. However, his WBC count decreased gradually to 200 cells/µL from 1200 cells/µL, before granulocyte colony stimulating factor was started [duration of treatment to reaction onset and outcome not stated]. His neutropenia was considered to be associated with the chemotherapy. Author comment: ’’The patient had neutropenia associated with the chemotherapy’’. Yamazaki S, et al. An extremely high bioavailability of orally administered vancomycin in a patient with severe colitis and renal insufficiency. Journal of Infection and Chemotherapy 23: 848-851, No. 12, Dec 2017. Available from: URL: http://doi.org/10.1016/j.jiac.2017.08.004 - Japan 803284845 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud